Summary & Overview
HCPCS S2103: Adrenal Tissue Transplant to Brain
HCPCS Level II code S2103 denotes an adrenal tissue transplant to the brain, a rare surgical transplant procedure that involves implanting adrenal tissue into intracranial sites. Nationally, this code is relevant for specialized neurosurgical and transplant programs, academic medical centers, and hospitals that provide experimental or highly specialized endocrine–neurosurgical interventions. The billing designation helps payers and providers classify and track utilization of a highly specialized surgical service.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how this code is used clinically, typical sites of service, and which major payers are relevant for coverage considerations. The publication also summarizes benchmarks where available, highlights policy and coding guidance changes when present, and provides clinical context about the procedure type and likely care settings.
The content is intended to inform coding professionals, revenue cycle teams, and policy analysts about the code’s definition, payer mix, and the operational context for billing and tracking this specialized transplant service at a national level.
Billing Code Overview
HCPCS Level II code S2103 represents adrenal tissue transplant to brain, a surgical or transplant procedure involving placement of adrenal tissue into intracranial sites. The service is best categorized as a surgical transplant procedure.
-
Service type: Surgical transplant
-
Typical site of service: Hospital inpatient or hospital outpatient surgical setting, and specialized transplant centers
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with refractory Parkinsonian symptoms or severe chronic pain being considered for experimental or salvage neural modulation when conventional therapies have failed. The procedure S2103 — adrenal tissue transplant to brain — involves transplantation of adrenal cortical or medullary tissue into intracranial sites (historically into the substantia nigra or other targets) to provide local neurochemical support. The clinical workflow begins with multidisciplinary evaluation including neurology/neurosurgery and endocrinology. Pre-procedure steps include neuroimaging (MRI brain), neuropsychological assessment, endocrine evaluation for adrenal donor suitability (autograft vs allograft), informed consent emphasizing investigational status and risks, and perioperative medication management.
On the day of service the patient undergoes general anesthesia in an operating room or hybrid OR with neurosurgical stereotactic guidance. The neurosurgeon obtains adrenal tissue (autologous via laparoscopic adrenalectomy or allogeneic from a prepared graft), prepares the tissue under sterile conditions, and transplants it into the targeted intracranial site using stereotactic technique. Postoperative care includes inpatient neurologic monitoring, imaging to confirm graft placement, endocrine monitoring for adrenal insufficiency or hormone effects, infection surveillance, and long-term neurology follow-up to assess symptomatic response. Typical sites of service are the hospital operating room or ambulatory surgical center with neurosurgical capabilities; post‑op care occurs in inpatient neurosurgical units or specialized recovery areas.
Coding Specifications
| Modifier | Description | When to Use |
|---|